Carbolieva 150mg

Carbolieva 150mg Injection is classified as an alkylating agent. This anti-cancer medication contains carboplatin as its active ingredient. It is used to treat specific types of ovarian and lung cancer, either alone or in combination with other treatments.

If you notice any signs of allergic reactions, unusual bruising, kidney issues (such as haemolytic-uraemic syndrome), or a reduction in red blood cells (anemia), consult your physician. Additionally, inform your doctor if you experience any lung-related symptoms, including shortness of breath, inflammation of lung tissue, or lung infections while undergoing treatment with Carbolieva 150mg Injection.

It is important to use effective contraception during the course of this medication and to continue its use for six months after the last dose. Carbolieva 150mg Injection may lead to temporary or permanent fertility reduction in both men and women, so it is recommended to discuss any fertility concerns with your healthcare provider.